J.P. Morgan Exchange-Traded Fund Trust (JDOC)
Management Company · NASD · Series S000080528 · View on SEC EDGAR ↗
$57.09
As of March 10, 2026
▼ -0.16 (-0.28%)
1-day change
$47.67 – $59.69
52-week range
- Net assets
- $11.1M
- Holdings
- 66
- As of
- April 30, 2026 stale
- Top 10 holdings weight
- 46.55%
- Effective number of positions
- 31.7
- Positions above 1%
- 32
On this page
- Price chart The fund's market price over time, with technical overlays.
- Performance Total return, volatility, drawdown and other risk metrics.
- Fund flows Money flowing in and out of the fund each month, from N-PORT filings.
- Holdings Every position the fund currently holds, with weights.
- Sector breakdown How the fund's holdings split across market sectors.
- Institutional owners 13F institutions that report holding this ETF.
- Similar funds Other funds with overlapping holdings or comparable size.
JDOC Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
Performance as of March 10, 2026
| Period | Price return | Total return |
|---|---|---|
| 1M | ▼ -2.27% | — |
| 3M | ▼ -1.14% | — |
| 6M | ▲ +10.45% | — |
| YTD | ▼ -1.31% | — |
| 1Y | ▲ +6.53% | — |
| 3Y | — | — |
| 5Y | — | — |
| Max since Feb. 27, 2024 | ▼ -1.56% | — |
- Volatility 1Y
- 16.71%
- Volatility 3Y
- —
- Max drawdown 3Y
- —
- Beta 3Y
- —
- Sharpe 1Y*
- 0.47
Total return is shown once dividend history for this fund has been collected — price return alone would duplicate it misleadingly. Returns are not benchmarked against an index. * Sharpe ratio is computed with a 0% risk-free rate.
Fund flows (SEC-reported)
- Last month (Apr 2026)
- +$1.4M
- Quarter ending Apr 2026
- +$2.8M
- Trailing 12 months
- +$2.8M
May 2025 – Apr 2026
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 66 holdings
| Name | CUSIP | Value | % | Balance | Category | Country |
|---|---|---|---|---|---|---|
| Eli Lilly & Co. | 532457108 | $758K | 6.81 | 811 | EC | US |
| AbbVie, Inc. | 00287Y109 | $732K | 6.58 | 3,464 | EC | US |
| Johnson & Johnson | 478160104 | $690K | 6.20 | 3,001 | EC | US |
| UnitedHealth Group, Inc. | 91324P102 | $649K | 5.83 | 1,751 | EC | US |
| AstraZeneca plc | — | $508K | 4.57 | 2,677 | EC | GB |
| Merck & Co., Inc. | 58933Y105 | $468K | 4.21 | 4,289 | EC | US |
| Bristol-Myers Squibb Co. | 110122108 | $389K | 3.50 | 6,427 | EC | US |
| Thermo Fisher Scientific, Inc. | 883556102 | $354K | 3.19 | 740 | EC | US |
| Intuitive Surgical, Inc. | 46120E602 | $329K | 2.96 | 719 | EC | US |
| CVS Health Corp. | 126650100 | $301K | 2.71 | 3,618 | EC | US |
| Novo Nordisk A/S | — | $295K | 2.65 | 6,943 | EC | DK |
| Roche Holding AG | — | $295K | 2.65 | 723 | EC | CH |
| Hoya Corp. | — | $261K | 2.35 | 1,400 | EC | JP |
| Regeneron Pharmaceuticals, Inc. | 75886F107 | $243K | 2.19 | 344 | EC | US |
| Boston Scientific Corp. | 101137107 | $227K | 2.04 | 3,946 | EC | US |
| UCB SA | — | $219K | 1.97 | 803 | EC | BE |
| Vertex Pharmaceuticals, Inc. | 92532F100 | $218K | 1.96 | 510 | EC | US |
| Danaher Corp. | 235851102 | $212K | 1.90 | 1,184 | EC | US |
| Edwards Lifesciences Corp. | 28176E108 | $203K | 1.83 | 2,435 | EC | US |
| McKesson Corp. | 58155Q103 | $198K | 1.78 | 243 | EC | US |
| Stryker Corp. | 863667101 | $177K | 1.59 | 562 | EC | US |
| Argenx SE | — | $171K | 1.54 | 218 | EC | NL |
| Teva Pharmaceutical Industries Ltd. | — | $157K | 1.41 | 4,466 | EC | IL |
| Cardinal Health, Inc. | 14149Y108 | $154K | 1.38 | 796 | EC | US |
| Centene Corp. | 15135B101 | $147K | 1.32 | 2,739 | EC | US |
| Biogen, Inc. | 09062X103 | $145K | 1.30 | 764 | EC | US |
| Zoetis, Inc. | 98978V103 | $131K | 1.17 | 1,136 | EC | US |
| United Therapeutics Corp. | 91307C102 | $129K | 1.16 | 226 | EC | US |
| Lonza Group AG | — | $123K | 1.11 | 200 | EC | CH |
| Novartis AG | — | $116K | 1.04 | 783 | EC | CH |
| Fresenius SE & Co. KGaA | — | $115K | 1.04 | 2,383 | EC | DE |
| IQVIA Holdings, Inc. | 46266C105 | $115K | 1.03 | 726 | EC | US |
| Sartorius AG | — | $102K | 0.91 | 398 | EC | DE |
| Spyre Therapeutics, Inc. | 00773J202 | $99K | 0.89 | 1,327 | EC | US |
| Apogee Therapeutics, Inc. | 03770N101 | $95K | 0.86 | 1,152 | EC | US |
| Ionis Pharmaceuticals, Inc. | 462222100 | $94K | 0.84 | 1,257 | EC | US |
| Argenx SE | — | $91K | 0.82 | 116 | EC | NL |
| CG oncology, Inc. | 156944100 | $87K | 0.78 | 1,304 | EC | US |
| Ascendis Pharma A/S | — | $79K | 0.71 | 343 | EC | DK |
| Align Technology, Inc. | 016255101 | $77K | 0.69 | 437 | EC | US |
| Immunome, Inc. | 45257U108 | $77K | 0.69 | 3,351 | EC | US |
| Dyne Therapeutics, Inc. | 26818M108 | $75K | 0.67 | 4,266 | EC | US |
| JPMorgan Securities Lending Money Market Fund | 46645V642 | $71K | 0.64 | 71,313 | STIV | US |
| Dexcom, Inc. | 252131107 | $71K | 0.64 | 1,196 | EC | US |
| Neurocrine Biosciences, Inc. | 64125C109 | $70K | 0.63 | 533 | EC | US |
| Genmab A/S | — | $70K | 0.63 | 265 | EC | DK |
| Daiichi Sankyo Co. Ltd. | — | $68K | 0.61 | 4,200 | EC | JP |
| Convatec Group plc | — | $67K | 0.61 | 23,481 | EC | GB |
| Cigna Group (The) | 125523100 | $67K | 0.60 | 231 | EC | US |
| Medtronic plc | — | $65K | 0.59 | 808 | EC | IE |
Page 1
of 2
← Previous
Next →
Sector breakdown
Healthcare
74.1%
Other/Unmapped
25.9%
Institutional owners (13F) 6 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| JPMORGAN CHASE & CO | $5,353,127 | 84.53% | 88,196 | Shares | June 30, 2026 |
| CITADEL ADVISORS LLC | $449,318 | 7.10% | 7,460 | Shares | June 30, 2026 |
| Krilogy Financial LLC | $266,640 | 4.21% | 4,427 | Shares | June 30, 2026 |
| Sanctuary Advisors, LLC | $250,087 | 3.95% | 4,152 | Shares | June 30, 2026 |
| ROYAL BANK OF CANADA | $7,000 | 0.11% | 120 | Shares | June 30, 2026 |
| WELLS FARGO & COMPANY/MN | $6,384 | 0.10% | 106 | Shares | June 30, 2026 |
Peer funds
More from this issuer
| Fund | AUM |
|---|---|
| JPST J.P. Morgan Exchange-Traded Fun… | $38.4B |
| BBJP J.P. Morgan Exchange-Traded Fun… | $16.6B |
| JCPB J.P. Morgan Exchange-Traded Fun… | $12.4B |
| BBCA J.P. Morgan Exchange-Traded Fun… | $10.7B |
| JIRE J.P. Morgan Exchange-Traded Fun… | $10.6B |
| JPIE J.P. Morgan Exchange-Traded Fun… | $9.1B |
| BBEU J.P. Morgan Exchange-Traded Fun… | $9.0B |
| JBND J.P. Morgan Exchange-Traded Fun… | $8.1B |
| BBUS J.P. Morgan Exchange-Traded Fun… | $7.8B |
| JMUB J.P. Morgan Exchange-Traded Fun… | $7.8B |
Similar by size
| Fund | AUM |
|---|---|
| RDOG ALPS ETF Trust | $11.2M |
| JDIV J.P. Morgan Exchange-Traded Fun… | $11.2M |
| EMES Harbor ETF Trust | $11.2M |
| FEAT Tidal Trust II | $11.3M |
| QQQG Pacer Funds Trust | $11.3M |
| PEX ProShares Trust | $11.1M |
| TYO Direxion Shares ETF Trust | $11.1M |
| MAPP Harbor ETF Trust | $10.9M |
| REK ProShares Trust | $10.9M |
| CPII AMERICAN BEACON SELECT FUNDS | $10.7M |